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MYBL2 and ATM suppress replication stress in
pluripotent stem cells
Daniel Blakemore1, Nuria Vilaplana-Lopera1 , Ruba Almaghrabi1, Elena Gonzalez1, Miriam Moya1,
Carl Ward2,3, George Murphy4, Agnieszka Gambus1 , Eva Petermann1 , Grant S Stewart1,† &
Paloma Garcıa1,*,†
Abstract
Replication stress, a major cause of genome instability in cycling
cells, is mainly prevented by the ATR-dependent replication stress
response pathway in somatic cells. However, the replication stress
response pathway in embryonic stem cells (ESCs) may be different
due to alterations in cell cycle phase length. The transcription
factor MYBL2, which is implicated in cell cycle regulation, is
expressed a hundred to a thousand-fold more in ESCs compared
with somatic cells. Here we show that MYBL2 activates ATM and
suppresses replication stress in ESCs. Consequently, loss of MYBL2
or inhibition of ATM or Mre11 in ESCs results in replication fork
slowing, increased fork stalling and elevated origin firing. Addition-
ally, we demonstrate that inhibition of CDC7 activity rescues
replication stress induced by MYBL2 loss and ATM inhibition,
suggesting that uncontrolled new origin firing may underlie the
replication stress phenotype resulting from loss/inhibition of
MYBL2 and ATM. Overall, our study proposes that in addition to
ATR, a MYBL2-MRN-ATM replication stress response pathway func-
tions in ESCs to control DNA replication initiation and prevent
genome instability.
Keywords B-MYB; DNA damage; ESCs; iPSC; origin firing
Subject Categories DNA Replication, Recombination & Repair; Stem Cells &
Regenerative Medicine
DOI 10.15252/embr.202051120 | Received 17 June 2020 | Revised 10 February
2021 | Accepted 19 February 2021
EMBO Reports (2021) e51120
Introduction
DNA replication is a highly complex process that requires tight regu-
lation to ensure that genome stability is maintained. Obstacles to
DNA replication activate the replication stress response pathway,
which not only functions to ensure that the initiation of DNA
replication and progression through the cell cycle progression are
suppressed, but also acts to facilitate the repair and restart of
damaged replication forks (Bartek et al, 2004; Aguilera & Gomez-
Gonzalez, 2008; Zeman & Cimprich, 2014).
Two main serine/threonine protein kinases are responsible for
controlling the cellular response to genetic damage and impediments
to DNA replication: ataxia-telangiectasia mutated (ATM) and ataxia-
telangiectasia and Rad3 related (ATR). ATR is activated following its
recruitment to RPA coated ssDNA, a common intermediate that
occurs during normal DNA replication and also as a consequence of
replication stress. It has been shown that ATR is essential for the
survival of proliferating cells as its loss is embryonic lethal (de Klein
et al, 2000). In contrast, ATM is recruited by the MRN complex to
DNA ends and is primarily associated with signalling the presence of
DNA double-strand breaks (DSB) (Uziel et al, 2003; Lee & Paull,
2005). Activation of the ATR kinase during replication leads to the
phosphorylation and activation of the CHK1 kinase, which functions
to suppress new replication origin firing (Guo et al, 2000; Liu et al,
2000; Moiseeva et al, 2019), promote fork stability and prevent
premature entry into mitosis (Cimprich & Cortez, 2008). In contrast,
it is thought that ATM is activated during S-phase only upon MRN-
dependent recruitment to sites of DSBs, i.e. collapsed replication
forks (Bakkenist & Kastan, 2003; Lee & Paull, 2004). However, vari-
ous studies have challenged this canonical pathway for ATM activa-
tion by demonstrating that its recruitment and activity is dependent
upon chromatin context, indicating that ATM may be capable of
being activated in the absence of DSBs (Bakkenist & Kastan, 2003;
Ewald et al, 2008; Bencokova et al, 2009; Cam et al, 2010; Olcina
et al, 2010; Olcina et al, 2013; Iwahori et al, 2014). Furthermore,
studies performed in Xenopus laevis egg extracts have indicated a
specific role for ATM in regulating the timing of replication (Marhei-
neke & Hyrien, 2004; Shechter et al, 2004). Therefore, it has been
hypothesized that ATM could have additional roles in replication
control, specifically in non-somatic cell types.
In embryonic stem cells (ESCs), safeguarding genome stability
during DNA replication is of extreme importance as alterations to
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the genome will be transmitted to their differentiated daughter cells
during development, potentially compromising tissue integrity and
function. Human and mouse ESCs proliferate very rapidly and
possess an atypical cell cycle with short GAP phases and a weak G1-
S checkpoint (Savatier et al, 1994; Ballabeni et al, 2011; Coronado
et al, 2013; Kapinas et al, 2013). It has been suggested that mouse
embryonic stem cells (mESCs) may contain a significant fraction of
unreplicated DNA as they enter mitosis (Ahuja et al, 2016). Never-
theless, despite these traits, pluripotent stem cells actually have a
very low mutation rate (Cervantes et al, 2002; Fujii-Yamamoto et al,
2005; Kapinas et al, 2013) and maintain genome stability more effi-
ciently than somatic cell types (Murga et al, 2007; Kapinas et al,
2013; Zhao et al, 2015; Ahuja et al, 2016). However, how these cells
retain such a low mutational rate in the presence of high levels of
endogenous replication stress is still not properly understood.
One protein that is unusually highly expressed in human and
mouse ESCs and key for genome stability is the transcription
factor MYBL2 (alias, B-MYB) (Sitzmann et al, 1996; Tarasov
et al, 2008; Lorvellec et al, 2010). Similar to ATR, targeted
disruption of MYBL2 leads to early embryonic lethality (Tanaka
et al, 1999). MYBL2 has been shown to be important for transac-
tivating the promoters of genes responsible for regulating the G2/
M transition (Osterloh et al, 2007; Tarasov et al, 2008; Knight
et al, 2009; Lorvellec et al, 2010; Wolter et al, 2017). More specif-
ically, the MuvB core cooperates with MYBL2 to recruit FOXM1
to the promoters of specific genes, such as Cyclin B and survivin
the CDC25 phosphatases, which are responsible for mediating
G2–M checkpoint control (Lefebvre et al, 2010; Martinez &
Dimaio, 2011; Down et al, 2012; Sadasivam et al, 2012; Sadasi-
vam & DeCaprio, 2013). In addition to this, a recent study identi-
fied a signalling axis, involving ATR-CDK1-FOXM1 and
demonstrated that it cooperates with MYBL2 to govern the proper
exit from S-phase into G2 (Saldivar et al, 2018). Moreover, it has
also been shown that YAP, a component of the HIPPO signalling
pathway, interacts with the MYBL2-MuvB complex to influence
the expression of genes important for mitosis (Pattschull et al,
2019). Whilst the ability of MYBL2 to act as a transcription factor
is critical for cell cycle regulation, our previous work in mouse
ESCs has highlighted the importance of MYBL2 for maintaining
normal replication fork progression under unperturbed conditions,
as stem cells lacking MYBL2 displayed a significant reduction in
replication fork speed (Lorvellec et al, 2010). However, whether
this replication phenotype is caused by dysfunction of the ATR-
CDK1-FOXM1 axis or aberrant regulation of YAP-dependent gene
transcription remains unknown. Here, we demonstrate that the
replication stress caused by loss of MYBL2 in mouse ESCs is
epistatic with loss of Mre11 or ATM function and can be rescued
by suppressing origin firing via inhibition of CDC7. This suggests
that uncontrolled replication initiation underlies the replication
stress phenotype exhibited by cells lacking MYBL2 and that it is
not caused by alterations in the expression of genes involved in
controlling the cell cycle. Taken together, this work identifies
ATM as a critical regulator of origin firing in pluripotent stem
cells and highlights the importance of MYBL2-ATM in controlling
the initiation of origin firing and the replication stress response in
these cells.
Results
Mybl2D/D ESCs display a replication stress phenotype
characterized by a decrease in replication fork speed and an
increase in replication fork instability
Consistent with our previous work (Lorvellec et al, 2010), DNA fibre
analysis revealed that replication fork progression was significantly
reduced in Mybl2D/D ESCs compared to a WT counterpart, with a
65% reduction in the median replication fork speed (Figs 1A and
EV1A). Analysis of the relative percentage of different replication
structures revealed a notable decrease in the percentage of elongat-
ing forks in the Mybl2D/D ESCs compared to Mybl2+/+ ESCs (Fig
EV1B and C). This reduction in actively elongating replication fork
structures was associated with an increase in fork stalling and new
origin firing, the latter of which is a known compensation mecha-
nism invoked to counteract a reduction in the cellular replicative
capacity (Fig EV1D and E).
To further investigate potential changes in the kinetics of replica-
tion fork progression, the ratio of first and second label replication
▸Figure 1. Mybl2D/D ESCs display fork instability and a replication stress phenotype leading to unreplicated DNA, Increase replication-associated DSB andgenome instability.
A Distribution curve of replication fork rates for Mybl2+/+ and Mybl2D/D ESCs. Statistical analysis was performed using the Mann–Whitney U-test. n = 6 experimental
replicates. A minimum of 490 replication forks were counted (****P < 0.0001).
B Left panel: representative elongating replication forks (stable and unstable). Quantification of the average IdU/CldU ratio in the Mybl2+/+ and Mybl2D/D ESCs.
Percentage of highly unstable forks (ratio above 2) are indicated. Y-axis was cut to change scale and display large values. Statistical analysis was performed using the
Mann–Whitney U-test (****P < 0.0001). At least 450 ratios were recorded from 6 experimental replicates.
C The length of both CldU labels surrounding IdU tracks (newly fired origins) was measured before calculating a ratio representing symmetry around new origins.
Quantification of the average positive ratio in the Mybl2+/+ and Mybl2D/D ESCs. Y-axis was cut to change scale and display large values. Statistical analysis was
performed using the Mann–Whitney U-test. 55 and 75 ratios were recorded in the Mybl2+/+ and Mybl2D/D, respectively, from three replicates (****P < 0.0001).
D Representative image showing the presence of UFB by positive Immunostaining for PICH. (Scale bar 10 lm). Frequency of anaphases positive for UFBs relative to all
anaphases in the Mybl2+/+ and Mybl2D/D ESCs. At least 75 anaphases were counted per experimental group from three independent experiments. Statistical analysis
was performed using an unpaired two-tailed t-test (****P < 0.0001).
E Representative images for comets in Mybl2+/+ and Mybl2D/D untreated and Mybl2+/+ and Mybl2D/D plus CPT (20× magnification). (Scale bar 50 lm).
F Quantification of the mean and distributions of olive tail moments in Mybl2+/+ and Mybl2D/D untreated and CPT-treated. Y-axis was cut to change scale and display
large values. Statistical analysis using Mann–Whitney U-tests. At least 300 comets were measured for each group from 5 experimental replicates (****P < 0.0001).
G Frequency of EdU-positive cells with over 6 53BP1 foci in Mybl2+/+, Mybl2D/D untreated and Mybl2+/+ and Mybl2D/D plus CPT. Error bars represent SEM. Statistical
analysis using unpaired two-tailed t-test. At least 200 EdU-positive nuclei were analysed from 4 experimental repeats.
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tracks of elongating forks was calculated as a measure of replication
fork stability (Maya-Mendoza et al, 2018). An increase in the ratio
with respect to wild-type cells suggests a disruption of continuous
fork progression due to increased fork instability. Notably, the
Mybl2D/D ESCs exhibited a significant increase in replication fork
instability compared to Mybl2+/+ ESCs (Fig 1B). In keeping with this
observation, Mybl2D/D ESCs also displayed a strong asymmetry
phenotype of newly fired replication forks initiating from the same
origin when compared to Mybl2+/+ ESCs (Fig 1C). This indicates
that MYBL2 plays a critical role in maintaining replication fork
stability in the absence of exposure to any exogenous genotoxins.
It is known that prolonged replication stress leads to the forma-
tion of ultra-fine bridges (UFBs) between separating sister chro-
matids in anaphase due to the presence of under-replicated DNA
(Chan et al, 2018). To investigate whether loss of MYBL2 leads to
increased UFBs, immunofluorescence staining using an antibody to
PICH, a DNA translocase known to coat ultra-fine bridges during
anaphase (Baumann et al, 2007; Chan & Hickson, 2011) was carried
out on asynchronous Mybl2+/+ and Mybl2D/D ESCs. In the Mybl2+/+
ESCs, 20% of anaphases exhibited UFBs, which is comparable to
levels previously observed for normal stem cells (Broderick et al,
2015; Hengeveld et al, 2015; Saldivar et al, 2018). Strikingly, there
was a significant increase (60%) in the percentage of UFB-positive
anaphases in the Mybl2D/D compared to Mybl2+/+ ESCs (Fig 1D).
Overall, these data build upon our previous findings and strongly
demonstrate that MYBL2 loss in ESCs culminates in chronic replica-
tion stress leading to under-replicated DNA passing into mitosis.
Mybl2D/D ESCs exhibit increased replication-associated
genome instability
Cells under chronic replication stress exhibit elevated levels of DNA
damage that can be partly attributed to an increase in stalled forks,
which if left unresolved, are vulnerable to collapse into double-
strand breaks (DSBs) (Petermann et al, 2010; Zeman & Cimprich,
2014). Therefore, to determine whether the increased replication
stress present in MYBL2 deficient ESCs resulted in more replication-
associated DNA breakage, total DNA breaks were quantified using
an alkaline comet assay (Ostling & Johanson, 1984; Singh et al,
1988). Exposure of cells to camptothecin (CPT), a genotoxic agent
known to induce replication-associated DNA breakage, was used as
a positive control. Notably, the Mybl2D/D ESCs exhibited signifi-
cantly increased levels of spontaneous DNA breakage as measured
by the average olive tail moment (OTM) when compared to the
Mybl2+/+ ESCs (Fig 1E and F). Whilst the exposure of ESCs to CPT
elevated the DNA breakage to a level that was not significantly dif-
ferent between the two genotypes.
To ascertain whether the increase in OTM in Mybl2D/D ESCs was
due to DSB formation during replication, immunofluorescence was
performed using 53BP1 and EdU as markers of DSBs and cells in S-
phase, respectively. Again, exposure to CPT was used as a positive
control for replication-associated DNA breakage. We observed a
twofold increase in the percentage of S-phase nuclei displaying more
than six 53BP1 foci in Mybl2D/D cells (EdU positive) when compared
to the Mybl2+/+ ESCs (Fig 1G and Appendix Fig S1). As expected, in
response to CPT treatment, both the Mybl2+/+ and Mybl2D/D ESCs
exhibited a large increase in the percentage of cells with over six
53BP1 foci. These findings suggest that the increased spontaneous
DNA damage in the Mybl2D/D ESCs most likely arises as a conse-
quence of replication fork collapse.
Mybl2D/D ESCs fail to activate the DNA damage-activated, G2/M
cell cycle checkpoint
Given that Mybl2D/D ESCs show signs of chronic replication stress
(Fig 1A–C) leading to unreplicated DNA (Fig 1D) and DNA breakage
(Fig 1E and F), it would be expected that these cells would arrest in
S- or G2-phase of the cell cycle due to prolonged activation of the
DNA damage checkpoint response (Zeman & Cimprich, 2014). Inter-
estingly however, Mybl2D/D ESCs still retain the capacity to prolifer-
ate even in the presence of DNA damage. Since MYBL2 has been
shown to regulate the transcription of genes linked with cell cycle
regulation (Katzen et al, 1998; Tarasov et al, 2008; Sadasivam et al,
2012; Henrich et al, 2017; Saldivar et al, 2018), we hypothesized
that the capacity of the Mybl2D/D cells to continue cycling in the
presence of replication stress and DNA damage could be attributed
to deregulation of the DNA damage cell cycle checkpoints. To inves-
tigate this, Mybl2+/+ and Mybl2D/D cells were treated with CPT and
then DNA fibre analysis was used to monitor the DNA damage-
induced suppression of new origin firing as a marker of activation
of the intra-S-phase checkpoint. Unexpectedly, we did not observe a
reduction in new origin firing following exposure to CPT in Mybl2+/+
ESCs, rather, the level of new origin firing increased. In ESCs lack-
ing MYBL2, CPT treatment had no observable effect on the already
high level of new origin firing (Fig 2A). This suggests that like the
G1/S-phase checkpoint, murine ESCs do not retain the capacity to
activate the DNA damage-induced intra-S-phase checkpoint and that
the observed increase in new origin firing following exposure to
▸Figure 2. MYBL2-ablated ESCs fail to activate the DNA-damaged activated, G2/M checkpoint.A Cells were treated for 1.5 h with 5 µM CPT, before sequential addition of IdU and CldU for 20 min each. Frequency of new firing origins (relative to total structures
counted) from Mybl2+/+ and Mybl2D/D ESCs treated or not with CPT (n = 3 independent experiments; error bars indicate SEM). Statistical analysis using two-tailed
unpaired t-test (ns = no significant).
B Distribution of replication rate in Mybl2+/+ and Mybl2D/D ESC treated or not with CPT as above. Statistical analysis was carried out using unpaired Mann–Whitney
U-tests. A minimum of 200 forks were quantified for each of the genotypes and conditions shown from three independent repeats (*P < 0.05; **P < 0.01;
***P < 0.001; ****P < 0.0001).
C ESCs were treated with or without CPT for 4 h before 0.1 lg/ml colcemid was added during the final 3.5 h of treatment. Representative image of H3-pS10-positive
cells (turquoise) (Scale bar 10 lm). Frequency of H3-pS10-positive cells in Mybl2+/+ and Mybl2D/D ESCs. Data from three independent experiments. Error bars
represent SEM. Statistical analysis was carried out using a two-tailed unpaired t-test (*P < 0.05; **P < 0.01; ns = no significant).
D P-CDK1 (Tyr15), CDK1 and Beta-actin expression levels of Mybl2+/+ and Mybl2D/D ESCs with or without CPT treatment analysed by immunoblotting. Bar graph
represents average band density of P-CDK1 in Mybl2D/D ESCs relative to loading control and relative to the MYBL2+/+ from six repeats. Error bars represent SEM.
Statistical analysis was carried out using a two-tailed unpaired t-test (**P < 0.01).
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CPT represents an adaptive response of the cell to trigger more
origin firing when faced with high levels of replication stress. In
agreement with this, CPT treatment resulted in a significant slowing
of DNA replication in Mybl2+/+ ESCs, which was comparable to the
replication rate of untreated Mybl2D/D ESCs (Fig 2B). Interestingly,
the slow rate of replication of the Mybl2D/D ESCs was unaffected by
exposure to CPT, indicating that the compromised rate of replication
is sufficient to prevent any significant collisions between replication
machinery and CPT-induced abortive Top1 complexes.
To assess whether ESCs were also incapable of activating the
G2/M DNA damage checkpoint, Mybl2+/+ and Mybl2D/D ESCs were
treated with CPT and then the percentage of cells passing into mito-
sis in the presence of DNA damage was quantified using histone H3
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To prevent cells traversing through mitosis, cells were treated also
with colcemid, a tubulin depolymerizing agent which arrests cells in
metaphase (Fig 2C) (Li et al, 2005). As expected, robust activation
of the G2/M checkpoint by CPT was induced in the Mybl2+/+ ESCs
as measured by a significant reduction in H3-pS10 positive cells
(from 23.3 to 4.5%). Interestingly, exposure of Mybl2D/D ESCs to
CPT failed to induce a significant reduction in H3-pS10 positive
cells, indicative of an inability to activate the DNA damage-induced
G2/M checkpoint (Fig 2C). These data are consistent with the
role of MYBL2 in regulating the G2-M transition in the presence of
DNA damage.
A critical event facilitating the ability of cells to activate the G2/M
checkpoint is the WEE1-dependent phosphorylation of CDK1 on
tyrosine-15 (Tyr-15) (Heald et al, 1993; Watanabe et al, 1995).
Therefore, to ascertain whether the G2/M checkpoint defect
observed in the Mybl2D/D ESCs was caused by aberrant regulation of
CDK1, we utilized Western blotting to measure the levels of CDK1
Tyr-15 phosphorylation. This analysis revealed that Mybl2D/D ESCs
exhibited reduced levels of CDK1 phosphorylated on Tyr-15 when
compared to Mybl2+/+ ESCs, whilst no obvious variations in CDK1
protein levels were observed (Fig 2D). As expected, inhibition of the
WEE1 kinase completely abolished phospho-CDK1 levels in both
the Mybl2+/+ and Mybl2D/D ESCs (Appendix Fig S2). To analyse the
effect of additional stress upon CDK1 activity in the Mybl2D/D ESCs,
cells were treated with CPT for 4 h. Following CPT treatment,
Mybl2+/+ ESCs displayed an increase in the P-CDK1 (Tyr15) levels,
presumably reflecting the inhibition of CDK1 activity by cell cycle
checkpoint signalling. In contrast, CPT-treated Mybl2D/D ESCs did
not display any obvious increase in P-CDK1, consistent with these
cells lacking this DNA damage-activated checkpoint response
(Fig 2D). Overall, these data indicate that chronic loss of MYBL2 in
ESCs results in abnormal CDK1 activity leading to a weaker G2/M
cell cycle checkpoint.
Reduced CHK1 activation in MYBL2-ablated ESCs after exposure
to DNA damage
To investigate the underlying cause of the deregulated CDK1 activity
in Mybl2D/D cells, we focused on CHK1, which is the principal
checkpoint kinase acting downstream of ATR and is known to
be important for the suppression of origin firing and cell cycle
checkpoint activation through its ability to inhibit CDK1 and CDK2
(Petermann et al, 2010). Western blotting analysis of CHK1 in
unperturbed conditions showed that the level of phospho-CHK1
(Ser345) in the Mybl2D/D ESCs was slightly increased compared to
Mybl2+/+ ESCs (Fig 3A), which is consistent with the increased
spontaneous replication stress we have observed in these cells.
However, the level of P-CHK1 in the Mybl2D/D ESCs was signifi-
cantly reduced when compared to Mybl2+/+ ESCs following exposure
to CPT, suggesting that Mybl2D/D ESCs can not efficiently activate
CHK1 in response to certain types of genotoxic stress (Fig 3A).
To investigate further the mechanism of CHK1 activation in
ESCs, cells were treated with either an ATR (AZ20) or ATM
(KU60019) inhibitor for 2 h before subjecting the cells to 5 Gy ioniz-
ing radiation to induce DNA damage. In line with our previous
observation, Mybl2D/D ESCs failed to efficiently phosphorylate
CHK1 after exposure to IR as compared to the WT ESCs (Fig 3B).
Furthermore, treatment with the ATR inhibitor reduced the levels of
P-CHK1 in the ESCs irrespective of genotype (Fig 3B). Interestingly,
treatment with the ATM inhibitor also appeared to reduce the levels
of P-CHK1 in the Mybl2+/+ but not the Mybl2D/D, indicating not only
the presence of crosstalk between ATR and ATM signalling path-
ways with respect to CHK1 activation in ESCs but also that a loss of
MYBL2 compromises the ability of ATM to be activated (Fig 3B).
Moreover, the increased levels of spontaneous P-CHK1 observed in
the untreated Mybl2D/D ESCs were also reduced by the ATR inhibitor
but not the ATM inhibitor (Appendix Fig S3). Altogether, our data
suggest that CHK1 activation is dependent on both ATR and
ATM signalling and that MYBL2 may function upstream of ATM to
activate CHK1.
Inhibition of ATR signalling results in severe replication stress
independently of MYBL2
Mybl2D/D ESCs are unable to properly activate CHK1 in response to
exogenous DNA damage, suggesting a potential role for MYBL2 in
regulating the replication stress response downstream of ATM and
possibly ATR. To determine whether MYBL2 acts in one or both of
these replication stress response pathways, we utilized the ATR and
ATM inhibitors to ascertain whether the endogenous replication
stress observed in the Mybl2D/D ESCs was epistatic with inhibition
of the activity of either one of these kinases.
Initially, Mybl2+/+ and Mybl2D/D ESCs were treated with an ATR
inhibitor for 1.5 h before labelling active replication and performing
DNA fibre analysis (Fig EV2A). In both the Mybl2+/+ and Mybl2D/D
ESCs, ATR inhibition resulted in a highly significant decrease in
▸Figure 3. Proficient ATR-dependent CHK1 activation in MYBL2-ablated ESC.A Immunoblot showing the levels of phosphorylated CHK1 (Ser345) and GAPDH in the Mybl2+/+ and Mybl2D/D ESCs with or without CPT treatment (2.5 µM CPT for 4 h).
B Immunoblot showing the levels of P-CHK1 (Ser345) and CHK1 in irradiated Mybl2+/+, and Mybl2D/D ESCs with or without 3 h inhibitor treatment: ATR (AZ20, 5 µM)
and ATM (Ku60019, 10 µM). Cells were also exposed to 5 Gy irradiation before the final hour of inhibitor treatment. Bar graph (lower panel) represents average band
density of P-CHK1 in Mybl2D/D ESCs relative to CHK1 and relative to untreated cells. Mybl2+/+ from two independent repeats and Mybl2D/D ESCs from three
independent repeats. Error bars represent SD. Statistical analysis was carried out using a two-tailed unpaired t-test (*P < 0.05).
C Cells were treated for 1.5 h with 5 µM AZ20, before sequential addition of IdU and CldU for 20 min each. Dot plot representing the effect of ATR inhibition upon
replication rate in Mybl2+/+ and Mybl2D/D ESC. Statistical analysis of distributions was carried out using unpaired Mann–Whitney U-tests. A minimum of 240 forks
was quantified for each of the genotypes and conditions shown from two independent repeats (****P < 0.0001)
D Frequency of new firing origins (relative to total structures counted) from Mybl2+/+ and Mybl2D/D ESCs treated or not with ATR inhibitor AZ20. At least 500 replication
structures were counted per treatment from two independent repeats. Statistical analysis using two-tailed unpaired t-test (*P < 0.05; ns = no significant).
E Distribution and average of IdU/CldU fork ratio in Mybl2+/+ and Mybl2D/D ESCs with or without ATR inhibitor treatment. Percentage of highly unstable forks (ratio
above 2) are indicated. Dotted line at 1 indicates positive ratio. Y-axis was cut to change scale and display large values. Statistical analysis was carried out using the
Mann–Whitney U-test. At least 150 ratios were calculated per treatment group from two independent repeats (*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001).
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replication fork progression (Figs 3C and, EV2B and C). However,
inhibition of ATR only deregulated replication initiation in the
Mybl2+/+ but not the Mybl2D/D ESCs (Figs 3D and EV2D). To deter-
mine whether ATR inhibition affected fork stability, the ratio
between the lengths of first- and second-labelled tracks of elongating
forks was calculated. The average fork ratio in the Mybl2+/+ ESCs
treated with ATR inhibitor increased significantly when compared
to that of untreated cells (Figs 3E and EV2D), whereas in contrast,
fork instability only moderately increased in Mybl2D/D ESCs follow-
ing treatment with the ATR inhibitor (Figs 3E and EV2D). Overall,
these findings suggest that MYBL2 may function downstream of
ATR to regulate the response to replication stress in ESCs but that
loss of ATR has a much greater impact on replication fork stability
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ATM and MYBL2 function together to prevent replication stress
and genome instability in pluripotent stem cells
Given the severity of the replication stress phenotype induced
following ATR inhibition relative to that present in the Mybl2D/D
ESCs, it is conceivable that either MYBL2 only functions within a
subset of ATR-dependent responses to replication stress or acts
within a parallel pathway that facilitates the ATR-dependent replica-
tion stress response, i.e. a pathway regulated by ATM. Therefore, to
investigate a link between MYBL2 and ATM, Mybl2+/+, and Mybl2D/D
ESCs were treated with a chemical inhibitor of ATM before the addi-
tion of IdU and CldU to label actively replicating DNA (Fig 4A).
DNA fibre analysis revealed that replication fork progression in the
Mybl2+/+ ESCs was surprisingly sensitive to ATM inhibition, albeit
not as sensitive to ATR inhibition, with the median replication forks
rate decreasing to levels similar to Mybl2D/D ESCs (Fig 4B). Interest-
ingly, ATM inhibition in the Mybl2D/D ESCs had no additional effect
upon replication forks progression rate (Fig 4B) indicating that the
spontaneous replication stress present in the Mybl2D/D ESCs most
likely arises as a consequence of a compromised ATM-dependent
replication stress response pathway. Consistent with ATM and
MYBL2 functioning in the same pathway, inhibition of ATM led to a
significant increase in replication fork asymmetry and new origin
firing in Mybl2+/+ ESCs but not in the Mybl2D/D ESCs (Fig 4C and
D), which was not due to any alterations in cell cycle profile
(Fig EV3). However, in keeping with ATR playing a predominant
role in controlling the replication stress response in ESCs and ATM
facilitating this, combined inhibition of ATR and ATM reduced repli-
cation rates in ESCs irrespective of genotype to levels comparable to
those observed following inhibition of ATR alone (Fig EV2E).
To confirm that the treatment with ATM inhibitor was causing
replication stress similar to that seen in the Mybl2D/D ESCs, the
formation of UFBs following exposure to the ATM inhibitor was
assessed. As expected, the Mybl2+/+ ESCs treated with ATM inhi-
bitor accumulated under-replicated DNA, as evidenced by the high
percentage of cells displaying UFB-positive anaphases (70%).
Notably, ATM inhibition induced UFBs in Mybl2+/+ ESCs at a level
comparable to that observed in Mybl2D/D ESCs (Fig 4E). Next, we
asked the question whether the DNA damage in the Mybl2D/D ESCs
is mimicked by ATM inhibition in WT ESCs. To test this, Mybl2+/+
and Mybl2D/D ESCs were treated with an ATM inhibitor before
performing immunofluorescence staining for 53BP1 in cells also
treated with EdU (Fig EV4A). Inhibition of ATM in the Mybl2+/+
ESCs resulted in an increase in 53BP1 foci in EdU-positive cells with
a threefold increase in the percentage of cells with more than six
foci (Fig EV4B and C). In contrast, ATM inhibition in the Mybl2D/D
ESCs had no additional effect upon the already elevated levels of
53BP1 recruitment (Fig EV4B and C). Together, these data suggest
that MYBL2 functions upstream of ATM in ESCs to suppress replica-
tion stress and genome instability. Based on this, we treated
Mybl2+/+ and Mybl2D/D ESCs with CPT and used Western blotting to
directly monitor the activation of ATM using a phospho-specific
antibody to S1987; a validated marker of ATM autoactivation. Strik-
ingly, Mybl2D/D ESCs were unable to efficiently activate ATM
following the induction of DNA damage as compared to the
Mybl2+/+ ESCs (Fig 4F). Additionally, inhibition of CHK2 activity, a
direct target of ATM (Matsuoka et al, 2000), in the Mybl2D/D ESCs
had no additional effect on replication fork rates (Appendix Fig
S4A). These observations serve to strength the notion that MYBL2
is stem cell-specific activator of the ATM-dependent replication
stress response.
To verify our findings suggesting a role for ATM in regulating the
replication stress response in ESCs without using small molecule
inhibitors, we generated Atm/ ESCs and used DNA fibre analysis
to monitor replication stress. This analysis demonstrated that
genetic loss of ATM gave rise to a similar reduction in replication
fork speed to that which we had previously observed in the
Mybl2+/+ ESCs treated with an ATM inhibitor (Fig 4G). Importantly,
this reduced replication speed was not further reduced by treating
the Atm/ ESC with an ATM inhibitor, demonstrating that the
▸Figure 4. ATM kinase and MYBL2 function to regulate replication in pluripotent stem cells.A Scheme of the protocol. ESCs were treated with 10 µM KU60019 for 1.5 h before sequential addition of IdU and CldU for 20 min each. DNA was treated and
visualized as previously described.
B Distribution of replication rate after treatment with/without ATM inhibitor. Statistical analysis of distributions was carried out using an unpaired Mann–Whitney U-
test. n = 4. A minimum of 270 forks was measured for each condition (****P < 0.0001).
C Distribution of the average IdU/CldU ratio in Mybl2+/+ and Mybl2D/D ESCs with or without ATM inhibitor treatment. Percentage of highly unstable forks (ratio above
2) are indicated. Dotted line at 1 indicates positive ratio. Y-axis was cut to change scale and display large values. Statistical analysis was carried out using the Mann–
Whitney U-test. At least 260 ratios were calculated per treatment group from four separate experiments (****P < 0.0001).
D Frequency of new fired origins for Mybl2+/+ and Mybl2D/D ESCs with or without ATM inhibitor treatment. Error bars represent SEM. Statistical analysis was carried out
using unpaired t-test. At least 500 replication structures were counted per treatment group from four separate repeats.
E Frequency of anaphases positive for UFB positive cells (based on ERCC/PICH-positive immunostaining) for Mybl2+/+, the Mybl2D/D and the Mybl2+/+ treated for 2 h
with ATM inhibitor (KU60019). Data represent at least 100 anaphases from each group from two experimental repeats. Statistical analysis was performed using an
unpaired two-tailed t-test.
F Immunoblot showing the levels of phosphorylated ATM (Ser1987) and ATM in the Mybl2+/+ and Mybl2D/D ESCs with or without CPT treatment (10 µM CPT for 2 h).
Bar graph (lower panel) represents average band density of P-ATM in Mybl2D/D ESCs treated with CPT relative to ATM and relative to wild-type CPT-treated cells from
three independent repeats. Error bars represent SD. Statistical analysis was carried out using a two-tailed unpaired t-test.
G Distribution plot of replication speed in Mybl2+/+and ATM/ ESC treated or not for 90 min with 10 µM KU60019 (ATMi), before sequential addition of IdU and CldU
for 20 min each. Statistical analysis was carried out using the Mann–Whitney U-test. At least 200 replication forks were counted from 3 separate experiments for
wild type and ATM/ and two separate experiments for ATM/ treated with ATM inhibitor (****P < 0.0001).
H Quantification of the number of replication factories per cell for the different genotypes and treatments. A minimum of 65 early S-phase nuclei was counted per
condition from two independent repeats. Statistical analysis was performed using a two-tailed unpaired unequal variance t-test (****P < 0.0001).
I Distribution plot of replication speed in human iPSC and MEFs (primary and immortal). Statistical analysis was carried out using the Mann–Whitney U-test. At least
400 replication forks for iPSC, 200 for primary MEFS and 250 for immortal MEFs were counted from 3 independent experiments (****P < 0.0001).
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replication stress phenotype induced by the ATM inhibitor did not
arise due to off-target effects (Fig 4G). To investigate the role of
ATM in suppressing replication stress further, we sought to deter-
mine whether loss of ATM activity could also lead to deregulation
of replication factories. The number of replication factories in early
S-phase was scored using Imaris program after cells were subjected
to a short pulse of IdU. As previously reported, Mybl2D/D ESCs
displayed an increase in the number of replication factories when
compared to Mybl2+/+ ESCs (Figs 4H and EV4D). In agreement with
our previous observations, both Mybl2+/+ ESCs treated with ATM
inhibitor, as well as Atm/ ESCs also displayed an increase in
number of replication factories (Fig 4H). Altogether, these data
suggest that pluripotent stem cells rely on both the ATR and ATM
kinases for proper replication progression in unperturbed conditions
and that MYBL2 is a key component of the ATM replication stress
response pathway in ESCs.
Whilst our data are in line with a role for ATM in regulating
replication in ESCs, since we have only used murine ESCs in our
study, we felt that it was imperative to demonstrate that a similar
phenomenon was also observed in other pluripotent stem cells but
not in somatic cells. To this end, we carried out DNA fibre analysis
on human induced pluripotent stem cells (iPSC) and primary/im-
mortalized mouse embryonic fibroblasts (MEFs) in the presence or
absence of an ATM, CHK2, or ATR inhibitor. Consistent with our
findings using murine ESCs, the ATM, CHK2, and ATR inhibitors
induced a significant reduction in replication fork speed in the
human iPSCs (Fig 4I and Appendix Fig S4B and C). However, the
ATM or CHK2 inhibitor did not result in a significant reduction in
fork speed in the primary and immortal MEFs (Fig 4I and
Appendix Fig S4B and C). Moreover, similar to what we had
observed in ESCs, exposure of iPSCs to the ATM inhibitor also
increased the formation of UFBs (Appendix Fig S4D). These data
confirm that ATM plays a role in suppressing replication stress in
pluripotent stem cells but not somatic cells.
The replication stress phenotype in Mybl2D/D ESCs is epistatic
with loss of Mre11 nuclease activity
The MRN complex (MRE11-Rad50-NBS1) is a multi-functional
protein complex involved in DNA repair, DNA replication, and cell
cycle checkpoint activation in part through its ability to sense DNA
damage and activate the ATM/ATR-dependent DNA damage
response. Previously, it has been shown that MYBL2 interacts with
the MRN complex albeit the functional significance of this remains
unclear (Henrich et al, 2017). Given functional links between the
MRN complex, ATM, and MYBL2, we sought to investigate whether
the nucleolytic activity of MRE11, which is essential for its role in
regulating DNA repair, plays a role in the MYBL2-ATM-dependent
replication stress response pathway in ESCs. To test this, mirin, an
inhibitor of the 30–50 exonuclease activity of MRE11 (Dupre et al,
2008) was utilized. Mybl2+/+ and Mybl2D/D ESCs were treated with
mirin before treatment with IdU and CldU to label nascent DNA
synthesis (Fig 5A). DNA fibre analysis was performed, and the
effect of mirin on replication fork rates was determined. In Mybl2+/+
ESCs, there was a substantial decrease in replication fork rate
(Fig 5B), an increase in new origin firing (Fig 5D and E) and
elevated replication fork instability in response to mirin treatment
(Fig 5D and F). In contrast, mirin treatment had very little impact
on replication fork rates, new origin firing and replication fork
stability in the Mybl2D/D ESCs (Fig 5C–F). These data indicate that
both MYBL2 and the MRN complex are required for activation of
the ATM-dependent replication stress response in ESCs.
Origin firing is deregulated in Mybl2D/D ESCs and ATMi-treated
Mybl2+/+ ESCs
It is known that the DDR pathway primarily controls replication in
response to DNA damage by regulating origin firing via modulation
of CDK and CDC7 kinase activity (Costanzo et al, 2003; Syljuasen
et al, 2005; Patil et al, 2013; Zeman & Cimprich, 2014). Deregulation
of CDK activity has been demonstrated to be a major cause of repli-
cation stress partly due to aberrant origin firing (Petermann et al,
2010; Beck et al, 2012; Sorensen & Syljuasen, 2012; Anda et al,
2016). Since ATM/ATR-mediated inhibition of CDK1 is reduced in
Mybl2D/D ESCs (Fig 2), we initially sought to determine whether
inhibition of CDK1 or a combination of CDK2 and CDK1 could
rescue the replication defect observed in Mybl2D/D ESCs and wild-
type ESCs after suppression of ATM kinase activity. To investigate
this, both the Mybl2+/+ and Mybl2D/D ESCs were treated with a
CDK1 inhibitor (RO3306) before labelling of active replication and
DNA fibre spreading (Fig EV5A). Analysis of replication structures
revealed a very mild rescue of the elevated origin firing observed in
Mybl2D/D ESCs treated with CDK1 inhibitor and in Mybl2+/+ ESCs
after treatment with both CDK1 inhibitor and ATM inhibitor,
although these differences were not statistically significant
(Fig EV5B). Moreover, inhibition of CDK1 in the Mybl2D/D ESCs
partially normalized the replication fork speed to similar levels seen
in the Mybl2+/+ ESCs after CDK1 inhibition (Fig EV5C). Lastly,
▸Figure 5. Replication speed phenotype in Mybl2D/D ESCs is epistatic with loss of MRE-11 nuclease activity.A Scheme of the procedure before DNA spreading. Cells were treated for 1.5 h with 20 lM MRe11 inhibitor (mirin), before sequential addition of IdU and CldU for
20 min each.
B, C Distribution curve of replication fork rates for Mybl2+/+ and Mybl2D/D ESCs treated with mirin. Statistical analysis was performed using the Mann–Whitney U-test.
n = 3 experimental replicates. The value of the mean fork length is indicated above arrow (****P < 0.0001)
D Representative images of new firing origins, and elongating forks showing stable replication and fork instability.
E Frequency of new firing origins (relative to total structures counted) from Mybl2+/+ and Mybl2D/D ESCs treated or not with Mirin. At least 450 replication structures
were counted per treatment from three independent repeats. Error bars represent SEM. Statistical analysis using two-tailed unpaired t-test.
F Distribution and the average IdU/CldU ratio in Mybl2+/+ and Mybl2D/D ESCs with or without MRE11 inhibitor treatment. The length of both incorporated labels for
each elongating fork was measured in µm, and the positive ratio was calculated. Percentage of highly unstable forks (ratio above 2) are indicated. Dotted line at 1
indicates positive ratio. Y-axis was cut to change scale and display large values. Statistical analysis was carried out using the Mann–Whitney U-test. At least 260
ratios were calculated per treatment group from 3 separate experiments (****P < 0.0001).
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inhibition of CDK1 in ATM inhibited ESCs also resulted in a similar
partial rescue of the replication progression defect (Fig EV5C).
Based on this, we reasoned that a lack of inhibition of origin firing
following exposure to a CDK1 inhibitor could be due to a compen-
satory effect of CDK2, thus we sought to suppress origin firing by
inhibiting both CDK kinases (CDK1 and CDK2) by using the CDK1/2
inhibitor III (Higgs et al, 2015) (Fig EV5D). Similar to the CDK1i,
the CDK1/2 inhibitor also did not dramatically reduce origin firing
in Mybl2+/+ ESCs (neither at 3 lM nor at 25 lM) but did result in a
reduced rate of replication (Fig EV5E–G). In contrast, CDK1/2 inhi-
bition in Mybl2D/D ESCs and wild-type ESCs treated with an ATMi
lead to a reduction in origin firing and a partial rescue of fork speed
(Fig EV5E and F). From these observations, it would indicate that
neither CDK1 nor CDK2 play a major role in regulating new origin
firing in WT ESCs and the mild recovery of replication rates in
Mybl2D/D ESCs following CDK1/2 inhibition may arise as a conse-
quence of the slightly better suppression of new origin firing in
these cells.
In view of these results, we hypothesized that deregulation of
CDC7 may underlie the increased new origin firing and reduced
replication rates exhibited by Mybl2D/D ESCs (Fig 6A) (Jackson
et al, 1993; Yeeles et al, 2015). To test this, Mybl2+/+ and Mybl2D/D
ESCs were treated with the CDC7 inhibitor PHA-767491 (10 lM)
before labelling active replication forks (Fig 6B). In agreement with
this hypothesis, treatment of the Mybl2+/+ ESCs with a CDC7 inhi-
bitor resulted in a significant decrease in new origin firing (Fig 6C).
Moreover, the elevated origin firing observed in the Mybl2D/D ESCs
and in the Mybl2+/+ ESCs treated with ATM inhibitor was signifi-
cantly decreased to levels comparable to the Mybl2+/+ ESCs
(Fig 6C). Interestingly, whilst CDC7 inhibition had very little impact
on replication rates in Mybl2+/+ ESCs, remarkably, this resulted in a
complete rescue of replication fork speed in Mybl2D/D ESCs or WT
ESCs treated with an inhibitor (Fig 6D). In addition, inhibition of
CDC7 completely rescued replication fork stability in ESCs lacking
MYBL2 or ATM activity (Fig 6E). Importantly, our data indicates
that the CDC7-dependent increase in origin firing was not due to an
increase of CDC7 protein levels (Fig 6F). Together these data
suggest that the elevated levels of replication stress resulting from a
loss of MYBL2 or ATM activity is caused by aberrant CDC7-depen-
dent firing of replication forks and that a replication stress response
pathway regulated by MYBL2 and ATM function to modulate CDC7
activity to maintain genomic integrity (Fig 7).
Discussion
Embryonic stem cells possess unique cellular properties that are
tailored to their vital roles for successful development of the
mammalian embryo. Their capacity to differentiate into a diverse
array of functionally distinct cell types means that the acquisition of
detrimental mutations early in this process could have catastrophic
consequences for the whole embryo (Blanpain et al, 2011). Under
these circumstances, tight regulation of replication progression is
paramount to maintain genomic integrity in these cells. ATR has
been shown to be the principal replication stress-responsive kinase
required to maintain fork stability (Paulsen & Cimprich, 2007;
Cimprich & Cortez, 2008) and suppress the initiation of replication
in the presence of damaged DNA (Costanzo et al, 2003; Syljuasen
et al, 2005; Patil et al, 2013; Zeman & Cimprich, 2014). Consistent
with this role, our work shows that the inhibition of ATR in both
pluripotent stem cells (mouse ESCs and human iPSCs) as well as in
primary and immortal somatic cells (MEFs) leads to a slow down in
replication fork progression.
Importantly, our data also demonstrate a role for ATM, which is
normally activated exclusively in response to DSBs (Bakkenist &
Kastan, 2003; Shiloh, 2003; Lee & Paull, 2004), in regulating the repli-
cation stress response in ESCs, in part by facilitating the activation of
CHK1. Whilst the mechanisms with which ATM regulates replication
in ESCs have not been defined, it is clear that it does not function to
suppress new origin firing and regulate elongation through the
conventional CHK1-CDC25A-CDK2 DNA damage checkpoint path-
way that has been identified in somatic cells (Falck et al, 2001).
Rather, our data would indicate that CDC7 plays a more pivotal role
in regulating replication origin firing than CDKs in ESCs but whether
ATM directly or indirectly regulates CDC7 activation remains to be
determined. Despite this, our work raises several interesting ques-
tions: Why is ATM required to regulate the replication stress response
in ESCs and how does its activation in ESCs differ from that in
somatic cells? It has been recently demonstrated that ESCs are very
tolerant of high levels of replicative stress caused by a failure to
▸Figure 6. The replication defect observed after ATM inhibition and in Mybl2D/D ESCs is due to deregulation of cell cycle-associated replication initiationcontrol.
A, B Scheme of the aim and procedure before DNA spreading. Cells were treated for 1.5 h with ATM inhibitor (KU60019) or CDC7 inhibitor (PHA-767491) alone or in
combination, before sequential addition of IdU and CldU for 20 min each.
C Frequency of new firing origins (relative to total structures counted) from Mybl2+/+ and Mybl2D/D ESCs treated or not with the indicated inhibitors: CDC7 inhibitor
(PHA-767491) and/or ATM inhibitor (Ku60019). At least 300 replication structures were counted per treatment. Error bars represent SEM. Statistical analysis using
two-tailed unpaired t-test (*P < 0.05).
D Replication rate (kb/min) of Mybl2+/+ and Mybl2D/D ESCs treated with the indicated inhibitors. Statistical analysis was carried out using an unpaired Mann–Whitney
U-test (****P < 0.0001). Minimum three independent experiments. At least 270 forks were scored for non-ATM inhibitor-treated groups, and a minimum of 130 for
ATM inhibitor-treated groups.
E Fork stability (average IdU/CldU ratio) of Mybl2+/+ ESC and Mybl2D/D ESCs treated with the indicated inhibitors alone or in combination. At least 240 ratios were
calculated for non-ATM inhibitor-treated groups, and a minimum of 130 for ATM inhibitor-treated groups. Y-axis was cut to change scale and display large values.
Statistical analysis was carried out using Mann–Whitney U-test (****P < 0.0001). Data for Mybl2+/+ ESCs treated with ATM inhibitor alone or in combination with
CDC7 inhibitor were collected from two independent experiments. For the rest of the conditions, a minimum of three independent repeats was performed.
F Immunoblot showing the levels of CDC7 and actin in the Mybl2+/+ and Mybl2D/D ESCs. Bar graph (lower panel) represents average band density of CDC7 in
Mybl2D/D ESCs relative to actin and relative to Mybl2+/+ ESCs from three independent repeats. Error bars represent SD. Statistical analysis was carried out using a
two-tailed unpaired t-test (ns = no significant).
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complete replication in a single cell cycle. It has been suggested that
the increased propensity for replication forks in ESCs to undergo
reversal coupled with their high reliance on replication coupled-
repair mechanisms to deal with the under-replicated DNA allows
these cells to prevent fork collapse and chromosomal breakage in the
face of high levels of replication stress. Based on this, it is likely that
many critical regulators of DNA replication and the replication stress
response will be limiting and as a consequence, factors such as ATR
require aid from back up pathways, such as those regulated by ATM.
Conversely, whilst ESCs actively induce replication fork reversal to
maintain genome stability from the multiple rounds of discontinuous
replication, it is evident that this process is not infallible and as such,
DSBs do result from replication fork collapse. Therefore, it is conceiv-
able that this is why ESCs are more reliant on ATM to respond to
DNA damage arising in S-phase than somatic cells.
In relation to whether the activation of ATM in response to repli-
cation differs in ESCs from that in somatic cells, given that DSBs are
generated as a result of the unusual process of replication in ESCs
and that we have observed that MRN complex is required to
suppress replication stress, this would be consistent with the MRN
complex sensing DSBs and then activating ATM. However, it is
known that ESCs have a more relaxed chromatin state and that the
strength of DDR activation in these cells is dependent on the level of
chromatin compaction. Given that it has been previously shown that
ATM can be activated in the absence of DSBs by alternating chro-
matin accessibility (Bakkenist & Kastan, 2003), it is possible that the
increased chromatin accessibility in ESCs allows ATM to respond to
a wider spectrum of DNA lesions or structures than it usually would
in somatic cells where regions of eu- and heterochromatin are more
clearly defined. In addition to this, we have demonstrated that the
activation of the MRN-ATM-dependent replication stress response in
ESCs also requires MYBL2. Whilst it is not clear why MYBL2 is
required to activate the ATM-dependent replication stress response,
it has been previously shown that MYBL2 binds to the MRN
complex and is recruited to sites of DNA damage (Henrich et al,
2017). However, it was suggested that MYBL2 does not play a role
in regulating DNA repair and this interaction was associated with
activation of the DNA damage G2/M checkpoint through its ability
to act as a transcription factor (Henrich et al, 2017). In keeping with
this report, we observed that Mybl2D/D ESCs failed to properly acti-
vate the DNA damage-induced G2/M checkpoint but whether this
resulted from a reduction in the expression of genes involved in the
G2-M transition or a failure to properly activate CHK1 remains to be
determined. Nevertheless, our RNA-seq data from Mybl2D/D ESCs
did not identify any significant alterations in genes associated with
DNA replication suggesting that in ESCs MYBL2 maybe also be func-
tioning as a component of the replication stress response indepen-
dent of its role as a transcription factor.
Whilst our work clearly demonstrates that MYBL2, in conjunc-
tion with ATM, is important for suppressing replication stress in
ESCs, it is currently not known what the underlying cause is. Ahuja
et al (2016) reported that the endogenous high level of replication
stress present in ESCs does not arise as a consequence of high levels
of oxidative damage, deoxynucleotide (dNTP) depletion or
Figure 7. Schematic summary of our findings
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increased transcription–replication collisions but was rather due to
the very short G1 phase preventing sufficient time for replication
stress resolution. However, from our observations, it is clear that
the loss of MYBL2 or ATM significantly increases the levels of
endogenous cellular replication stress in ESCs without affecting the
length of G1 phase. Interestingly, we demonstrated that the high
levels of replication stress exhibited by ESCs lacking MYBL2 or
ATM could be rescued by a short incubation with a CDC7 inhibitor.
Although it was suggested by Ahuja et al (2016) that the rescue of
endogenous replication stress in ESCs following inhibition of CDC7
was solely due to a lengthening of G1 phase, this was achieved after
ESCs were released from a transient G1 arrest imposed by an 8 h
incubation with the CDC7 inhibitor (PHA-767491). In contrast, we
could observe a rescue of replication rates in MYBL2 or ATM-defi-
cient ESCs after a 1.5 h incubation with the same CDC7 inhibitor
and at the same concentration, which is unlikely to significantly
affect the duration of G1 phase.
Taken together, our work identifies ATM as a critical regulator of
the replication stress response pathway in ESCs and demonstrate
that MYBL2 functions to suppress replication stress, in part through
its ability to activate ATM. Furthermore, we believe these findings
are likely to have clinical ramifications since aberrant regulation of
MYBL2 may affect the sensitivity of tumour cells to inhibitors of the
ATM-dependent DNA damage response.
Materials and Methods
MYBL2 ablated mouse embryonic stem cells and ATM/ ESCs
generation and culture conditions
New Mybl2D/D ESCs were generated from Mybl2F/D mESCs (Garcia
et al, 2005) following the same protocol as previously described
(Lorvellec et al, 2010). Atm/ ESCs were derived from blastocysts
generated from Atm+/ crosses as previously described (Lorvellec
et al, 2010). ESCs were culture over mitomycin-treated MEFs feeder
layer, using the media previously described (Ward et al, 2018).
Mybl2D/D ESCs used in all experiments were not grown past 15
passages. Atm/ ESCs were used before passage five. Cells were
regularly tested for mycosplasma contamination.
Inhibitors/treatments
Cells were grown under different treatments as indicated in the fig-
ures. Colcemid Gibco, catalogue number 15212012; used at
0.27 µM. Topoisomerase I inhibitor: Camptothecin (CPT), C9911,
Sigma; used at 2.5–10 µM. CDK1 inhibitor: RO3306, 4181, Tocris;
used at 10 µM. CDC7 inhibitor: PHA-767491, 3140, Tocris; used at
10 µM. ATM inhibitor: KU60019, CAY17502-1, Cambridge
bioscience; used at 10 µM. ATR inhibitor: AZ20 5198, Tocris; used
at 10 µM. CHK2 inhibitor: BML-277, Sigma; used at 10 µM. MRE-11
inhibitor: mirin M9948, Sigma; used at 20 µM.
Western blotting
Western blotting was performed following standard procedures.
Lysis buffer was previously described (Lorvellec et al, 2010).
Primary antibodies: MYBL2 N19, sc724 (SCBT); P-CDK1 (Cdc2)
(Tyr15), 10A11 (Cell signalling); CDK1, A17 (Boster); P-Chk1
(Ser345), 133D3 (CST); CHK1, Sc8408 (SCBT); GADPH, Ab8245
(Abcam); B-actin, Sc1616 (SCBT); ATM 2C1 (Novus Biological); P-
ATM (AF1655) GeneTex; CDC7, 3603 (Cell Signaling Technology).
DNA fibres
Exponentially growing cells were subject to various chemical inhi-
bitors and stress inducing agents before labelling replicating DNA
through incorporation of thymidine analogues in culture. During
labelling, all media was pre-heated to 37°C before adding to cells.
Firstly, warm ESC media containing 30 µM iododeoxyuridine
(IdU; I7125, Sigma) was added for 20 min. Cells were washed
gently with warm media before addition of media containing
300 µM chlorodeoxyuridine (CldU; C6891, Sigma) for a further
20 min. Cell lysis and spreading and immunofluorescence were
performed as previously described (Lorvellec et al, 2010), using
Rat anti-BrdU/CldU (ab6326) and Mouse anti-BrdU/IdU (ab1816)
both from Abcam. Imaging was carried out on a Leica DM6000
fluorescence microscope, and images were taken at X60 magnifi-
cation. Analysis of fibres was performed using the LasX software
from Leica.
Replication factories
Embryonic stem cell colonies were exposed to experiment specific
treatments before addition of 20 µM IdU (I7125; Sigma) to the
media for 20 min. Immunofluorescence was performed as previ-
ously described using a mouse anti-IdU antibody (Invitrogen,
MD5000) (Lorvellec et al, 2010). Image acquisition was performed
using a Zeiss LSM 780 confocal immunofluorescence microscope.
During the early stages of S-phase, the nucleus presents numerous
small foci throughout the nucleoplasm, whereas, in mid/late S-
phase cells, replication factories aggregate at the nuclear periphery
before adopting a more clumped appearance (Ferreira & Carmo-
Fonseca, 1997; Dimitrova & Berezney, 2002). Colonies containing
early replicating cells were selected, and z-stack images were
acquired at 100× magnification with a distance of 0.4 µm between
each z slice. The images were then converted to 3D rendered
projections using Imaris (x64.3.1; Bitplane, Zurich, Switzerland).
An automatic foci counting tool within the Imaris software was
then used to automatically quantify the number of foci per
cell. This was through the spots function in the surpass tool.
Spots were defined as “growing regions” with an estimated diam-
eter of 0.3 lm.
BrdU Flow cytometry
Cells were treated with 25 lM BrdU for 1 h and BrdU staining
detected using FITC Mouse Anti-BrdU Set (BD Biosciences, 556028).
Cells were resuspended in 10 lg/ml 7-Amino-Actinomycin D (7-
AAD) (BD biosciences, 559925) for the detection of DNA content.
Analysis was performed using FlowJo.
Alkaline comet assays
5 × 104 ESCs were used per slide following the protocol previously
described (Bayley et al, 2018).
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Ultra-fine bridges
Experiment specific treatments were performed before washing
cells with ice-cold PBS and fixation through treatment with 4% (v/
v) PFA for 10 min. PFA was removed through PBS washes, and
formaldehyde groups were quenched through treatment with
50 mM ammonium chloride for 10 min. Cells were washed three
times more with PBS before adding ice-cold 100% methanol for
10 min. After repeating washes, cells were blocked in blocking
buffer, 10% (v/v) FBS, 1% BSA (w/v) and 0.3% (v/v) Triton X in
PBS, for 1 h at room temperature. Antibody staining was
performed using an anti-ERCC6 primary antibody (H00054821,
Abnova), 1 in 100 in blocking buffer at 4°C overnight, and an anti-
rabbit Alexa 488 secondary antibody (A31565, Thermo Fisher) at 1
in 500 in blocking for 1 h at room temperature. Slides were
mounted in prolong plus DAPI before storing at 20°C. Micro-
scopy was performed using a Leica DM6000 fluorescence micro-
scope; anaphase cells were visualized by DAPI staining; and the
percentage of anaphases with ultra-fine bridges was determined for
each sample.
Immunofluorescences
Cells were fixed in 4% paraformaldehyde for 20 min before washing
twice in PBS. Permeabilization and blocking were carried out
through treatment with blocking buffer containing 1% (w/v) BSA
and 0.3% (v/v) Triton X in PBS for 1 h at room temperature. Cells
were then incubated with a mouse anti-H3-pS10 (9701S) primary
antibody at a concentration of 1 in 200 in blocking buffer at 4°C
overnight or a rabbit anti-53BP1 primary antibody (Novus Biologi-
cals NB100-304) at 1 in 500 in blocking buffer at 4°C overnight. A
separate slide was also incubated with an anti-mouse IgG antibody
(Santa-cruz, sc2025) or rabbit IgG (sc-2027, Santa Cruz) for an IgG
control. Slides were washed twice in PBS before incubating with
goat anti-mouse Alexa 488 secondary or anti-rabbit Alexa 488
secondary antibody (A31565, Thermo Fisher). Imaging was
performed using a Leica DM6000 fluorescence microscope, and
images were taken at x40 magnification for 53BP1 staining or at 20×
magnification for H3-pSer10 staining. The number of 53BP1 foci per
nuclei/pr positive nuclei for H3-P-Ser10 was counted manually
using the counting plugin for ImageJ.
For detection of H3-pSer10, prior to fixation, ESCs were treated
with 2.5 µM CPT for 4 h; 0.1 lg/ml (0.27 µM) colcemid was
added for the final 3.5 h to arrest cells which pass into mitosis.
Cells were immediately harvested on ice before washing in PBS
and centrifugation at 250 g for 5 min at 4°C. 5 × 104 cells were
cytospin at 300 g for 5 min onto microscope slides and air-dried
for 15 min.
For detection of 53BP1 foci, 10 µM EdU (C10337, Thermo Fisher)
was added to cells in culture for 1 h before harvesting on ice and a
click-IT reaction, and a “click” reaction was performed after fixation
and permeabilization prior to antibody staining.
Detection of EdU through a click reaction
Staining of incorporated EdU was performed through a “click” reac-
tion representing the reaction between an alkyne (conjugated to
EdU) and an azide (fluorescently labelled). A reaction cocktail was
made containing 86% Tris-buffered saline (TBS; 50 mM Tris-Cl, pH
7.5, 150 mM NaCl), 4% (v/v) 100 mM CuSO4, 0.125% (v/v) Alexa-
fluor azide 594 (C10330, Thermo Fisher) and 10% (v/v) 1 M
sodium ascorbate added in the order presented. 200 µl of the reac-
tion cocktail was added to each slide under a coverslip and incu-
bated for 30 min in the dark. Slides were washed several times in
PBS before re-blocking for 30 min in blocking solution.
Data availability
No data generated in this study were deposited in public databases.
Expanded View for this article is available online.
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